Guardant Health (GH) Other financing activities (2018 - 2026)

Guardant Health (GH) has 8 years of Other financing activities data on file, last reported at $102000.0 in Q1 2026.

• Quarterly Other financing activities fell 99.16% year-over-year to $102000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.4 million (down 171.96% YoY) and the FY2025 annual result came in at $3.6 million, up 2450.33% from the prior year.
• Other financing activities declined to $102000.0 in Q1 2026 per GH's latest filing, from $765000.0 in the prior quarter.
• The five-year high for Other financing activities was $21.3 million in Q2 2023, with the low at -$15.4 million in Q3 2023.
• Average Other financing activities over 4 years is $1.9 million, with a median of $102000.0 recorded in 2026.
• The widest YoY moves for Other financing activities: up 9374.19% in 2025, down 2681.28% in 2025.
• Guardant Health's Other financing activities stood at $15.2 million in 2023, then plunged by 99.61% to $59000.0 in 2024, then soared by 1196.61% to $765000.0 in 2025, then tumbled by 86.67% to $102000.0 in 2026.
• Business Quant data shows GH's Other financing activities at $102000.0 in Q1 2026, $765000.0 in Q4 2025, and $2.9 million in Q3 2025.